217 related articles for article (PubMed ID: 22286552)
1. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus.
Hillis GS; Woodward M; Rodgers A; Chow CK; Li Q; Zoungas S; Patel A; Webster R; Batty GD; Ninomiya T; Mancia G; Poulter NR; Chalmers J
Diabetologia; 2012 May; 55(5):1283-90. PubMed ID: 22286552
[TBL] [Abstract][Full Text] [Related]
2. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
[TBL] [Abstract][Full Text] [Related]
3. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.
Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R
BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037
[TBL] [Abstract][Full Text] [Related]
4. Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus.
Hillis GS; Hata J; Woodward M; Perkovic V; Arima H; Chow CK; Zoungas S; Patel A; Poulter NR; Mancia G; Williams B; Chalmers J
J Am Heart Assoc; 2012 Oct; 1(5):e002832. PubMed ID: 23316296
[TBL] [Abstract][Full Text] [Related]
5. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
de Galan BE; Zoungas S; Chalmers J; Anderson C; Dufouil C; Pillai A; Cooper M; Grobbee DE; Hackett M; Hamet P; Heller SR; Lisheng L; MacMahon S; Mancia G; Neal B; Pan CY; Patel A; Poulter N; Travert F; Woodward M;
Diabetologia; 2009 Nov; 52(11):2328-2336. PubMed ID: 19688336
[TBL] [Abstract][Full Text] [Related]
6. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
Lowe G; Woodward M; Hillis G; Rumley A; Li Q; Harrap S; Marre M; Hamet P; Patel A; Poulter N; Chalmers J
Diabetes; 2014 Mar; 63(3):1115-23. PubMed ID: 24222348
[TBL] [Abstract][Full Text] [Related]
7. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Ukena C; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Marx N; Weber MA; Williams B; Yusuf S
Eur Heart J; 2020 Jan; 41(2):231-238. PubMed ID: 30590564
[TBL] [Abstract][Full Text] [Related]
8. The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Blomster JI; Zoungas S; Chalmers J; Li Q; Chow CK; Woodward M; Mancia G; Poulter N; Williams B; Harrap S; Neal B; Patel A; Hillis GS
Diabetes Care; 2014; 37(5):1353-9. PubMed ID: 24578358
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins.
Neugebauer R; Schroeder EB; Reynolds K; Schmittdiel JA; Loes L; Dyer W; Desai JR; Vazquez-Benitez G; Ho PM; Anderson JP; Pimentel N; O'Connor PJ
JAMA Netw Open; 2020 Jan; 3(1):e1918554. PubMed ID: 31977057
[TBL] [Abstract][Full Text] [Related]
10. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes.
Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150
[TBL] [Abstract][Full Text] [Related]
11. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.
Yoon JE; Sunwoo JS; Kim JS; Roh H; Ahn MY; Woo HY; Lee KB
J Diabetes Complications; 2017 Feb; 31(2):390-394. PubMed ID: 27956053
[TBL] [Abstract][Full Text] [Related]
12. Early specialist care for diabetes: who benefits most? A propensity score-matched cohort study.
Booth GL; Shah BR; Austin PC; Hux JE; Luo J; Lok CE
Diabet Med; 2016 Jan; 33(1):111-8. PubMed ID: 25981183
[TBL] [Abstract][Full Text] [Related]
13. Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.
Kelly PJ; Clarke PM; Hayes AJ; Gerdtham UG; Cederholm J; Nilsson P; Eliasson B; Gudbjornsdottir S
Diabet Med; 2014 Aug; 31(8):954-62. PubMed ID: 24750341
[TBL] [Abstract][Full Text] [Related]
14. A higher resting heart rate is associated with cardiovascular event risk in patients with type 2 diabetes mellitus without known cardiovascular disease.
Ikeda S; Shinohara K; Enzan N; Matsushima S; Tohyama T; Funakoshi K; Kishimoto J; Itoh H; Komuro I; Tsutsui H
Hypertens Res; 2023 May; 46(5):1090-1099. PubMed ID: 36707715
[TBL] [Abstract][Full Text] [Related]
15. A large frontal QRS-T angle is a strong predictor of the long-term risk of myocardial infarction and all-cause mortality in the diabetic population.
May O; Graversen CB; Johansen MØ; Arildsen H
J Diabetes Complications; 2017 Mar; 31(3):551-555. PubMed ID: 28065667
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies.
Evans JM; Wang J; Morris AD
BMJ; 2002 Apr; 324(7343):939-42. PubMed ID: 11964337
[TBL] [Abstract][Full Text] [Related]
17. Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohort.
Sharif S; Groenwold RHH; van der Graaf Y; Berkelmans GFN; Cramer MJ; Visseren FLJ; Westerink J;
Diabetes Obes Metab; 2019 Aug; 21(8):1935-1943. PubMed ID: 31062479
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.
Fuller JH; Stevens LK; Wang SL
Diabetologia; 2001 Sep; 44 Suppl 2():S54-64. PubMed ID: 11587051
[TBL] [Abstract][Full Text] [Related]
19. No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.
Gokhale M; Buse JB; Jonsson Funk M; Lund J; Pate V; Simpson RJ; Stürmer T
Diabetes Obes Metab; 2017 Jul; 19(7):970-978. PubMed ID: 28195389
[TBL] [Abstract][Full Text] [Related]
20. Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
Fox K; Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Hennerici MG; Mattle HP; Rothwell PM;
Int J Cardiol; 2013 Oct; 168(4):3500-5. PubMed ID: 23706327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
